Omega-3’s newest big fish reveals sector ambitions

Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through the ‘how’ and the ‘why’ of the move…and the ‘where’ it might lead.